AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06772103 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biceps Tenodesis with 360 Suture anchor
Description: The LHB tendon is detached from its origin and sutured. Next, the LHB tendon is fixed in the bicipital groove using a 360-loop tenodesis technique with the Knotless FiberTak® biceps implant system. A radiographically visible suture will be attached to the proximal part of the LHB tendon to facilitate subsequent localization of the LHB tendon during imaging (3-0 stainless steel, ethicon).
Study NCT04762186 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: human SARS-CoV 2 specific T lymphocytes
Description: In dose level one, SARS-CoV-2 infected patients will receive 1,000 viable human SARS CoV-2 specific T lymphocytes per kg BW.~In dose level two SARS-CoV-2 infected patients will receive 5,000 viable human SARS CoV-2 specific T lymphocytes per kg BW.~In parallel, all patients will receive the current SoC treatment for COVID-19.
Study NCT05156008 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Ultrasound-guided vascular access
Description: Patients in this arm will have peripheral venous cannula inserted under realtime ultrasound guidance. Out of plane technique (in plane technique if too deep when tip of the needle is on vessel wall) used by experienced physicians in UGVA. Out of plane technique strictly used in step by step manner. That means moving probe with the tip of the needle to always locate its exact position, all the way into the vein. All performed insertions are carried out by skilled operators in UGVA with out of plane technique. Just before surgery in block room.
Study NCT06209242 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Percutaneous pinning
Description: Using k- wire percutaneous pinning with local anesthesia with one-day surgery protocol
Study NCT06209242 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cast immobilization
Description: Using sugar tong slab and then replace to short arm casting within 1 week
Study NCT06478290 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: curcumin, omega-3, and vitamin D (COD)
Description: Combination of curcumin, omega-3, and vitamin D supplements (COD). Acumin™Turmeric Complex/Dr. D's Ultra BioTurmeric: 500 mg/day (oral, 2 tablets taken by mouth), Vitamin D: 2500 IU/day (oral, 1 tablet taken by mouth), Omega-3: 900 mg day (oral, 1 tablet taken by mouth)
Study NCT06197204 — intervention group
Intervention type: OTHER
Intervention: Blood sampling
Description: * at first visit in the reference center~* at each follow-up visit ( once a year)~* before and after specific treatment~* in case of flare
Study NCT06197204 — intervention group
Intervention type: OTHER
Intervention: Biopsy
Description: In case of flare
Study NCT06197204 — intervention group
Intervention type: OTHER
Intervention: Blood sampling
Description: Once at inclusion visit
Study NCT05496764 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: we planned to inject steroid( 4 mg of dexamethasone acetate combined with 1% lidocaine into the carpal tunnels) directly into the carpal tunnel in group A
Study NCT05496764 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glucose Injection
Description: inject10 ml glucose 5% into the carpal tunnel in group B
Study NCT05917340 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High dose rifampicin (25mg/kg)
Description: Given for 2 months
Study NCT05917340 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400mg
Description: Given for 2 months
Study NCT05917340 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin 150 mg
Description: Given for 2 months
Study NCT05917340 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isoniazid
Description: Given for 6 months
Study NCT05917340 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrazinamide
Description: Given for 6 months
Study NCT05917340 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Steroid
Description: Tapering dose of dexamethasone or prednisolone upto 8 weeks
Study NCT05917340 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampicin
Description: Standard dose for 4 months after the initial treatment with high dose
Study NCT05917340 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HRZE
Description: 2 months
Study NCT05917340 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HRE
Description: 7-10 months as per TB program guidelines
Study NCT05457959 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Dendritic Cell Tumor Peptide Vaccine
Description: Given ID
Study NCT05457959 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Dendritic Cell Tumor Peptide Vaccine
Description: Given ID
Study NCT05457959 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Ipilimumab
Description: Given IV
Study NCT05457959 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Given IV
Study NCT05457959 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Leukapheresis
Description: Undergo leukapheresis
Study NCT05457959 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Leukapheresis
Description: Undergo leukapheresis
Study NCT05457959 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Nivolumab
Description: Given IV
Study NCT05457959 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given IV
Study NCT05457959 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Administration
Description: Given ID
Study NCT05457959 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Administration
Description: Given IV
Study NCT05457959 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Administration
Description: Given IV
Study NCT05457959 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Poly ICLC
Description: Given IM
Study NCT05457959 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Poly ICLC
Description: Given IM
Study NCT05457959 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Resection
Description: Undergo standard of care surgical resection
Study NCT05457959 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Resection
Description: Undergo standard of care surgical resection
Study NCT06525519 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATLG
Description: 5 mg/kg/day IV for 4 consecutive days (day-5 to -2 before transplantation). All transplant recipients will receive myeloablative conditioning or modified myoloablative conditioning and standard GVHD prophylaxis.
Study NCT06525519 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATLG
Description: 7.5mg/kg/day IV for 4 consecutive days (day-5 to -2 before transplantation). All transplant recipients will receive myeloablative conditioning or modified myoloablative conditioning and standard GVHD prophylaxis.
Study NCT05709613 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Use of a chest compressions' feedback device
Description: The participants will have access to a chest compressions' feedback device
Study NCT06214884 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness for All
Description: Experimental:~The MFA will take place in a group setting with 10-15 participants per cluster. Due to participants' convenience, the delivery mode of each intervention session would be conducted online. At the end of session, they will be provided the task and supplementary materials (e-book, short audio, and video) to be apply after the session. The modules will be delivered by two trainees. Both trainees have received the certificates from the mindfulness-based strategic awareness training course. Participants in the intervention group will be joining the modules for 5 sessions weekly for 60-minute/session. Details on the modules can be referred in the Supplement material.
Study NCT06214884 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness for All
Description: Experimental:~The MFA will take place in a group setting with 10-15 participants per cluster. Due to participants' convenience, the delivery mode of each intervention session would be conducted online. At the end of session, they will be provided the task and supplementary materials (e-book, short audio, and video) to be apply after the session. The modules will be delivered by two trainees. Both trainees have received the certificates from the mindfulness-based strategic awareness training course. Participants in the intervention group will be joining the modules for 5 sessions weekly for 60-minute/session. Details on the modules can be referred in the Supplement material.
Study NCT05324189 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Referable versus Non Referable Diabetic Retinopathy diagnostic test
Description: Artificial intelligence read reports Referable versus Non Referable Diabetic Retinopathy
Study NCT06550648 — intervention group
Intervention type: PROCEDURE
Intervention: Right Heart Catheterization (Swan Ganz Catheter)
Description: Swan Ganz Catheter only for PAH patients, Using the swan ganz and pressure transducer
Study NCT06026397 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SK10
Description: Participants will be randomized to receive oral suspension of SK10 powder, includes SAD on Day 1 and 14-days MAD from Day 4 to Day 17.
Study NCT06026397 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants will be randomized to receive oral suspension of placebo, includes SAD on Day 1 and 14-days MAD from Day 4 to Day 17.
Study NCT05836623 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Radiolabelled CB307
Description: CB307 radiolabelled with 89-Zirconium (89Zr CB307): drug product is formulated at a concentration of 1 mg/mL (37 MBq)
Study NCT05836623 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CB307
Description: Trispecific Humabody® targeting CD137, prostate specific membrane antigen and human serum albumin
Study NCT06430489 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Description: inhaled nitrous oxide (1 hour at 50% concentration)
Study NCT06430489 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Medical air
Description: inhaled medical air (1 hour)
Study NCT05919134 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dentoblis
Description: dissolve the tablets in the mouth once a day for 4 weeks
Study NCT05919134 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: dissolve the tablets in the mouth once a day for 4 weeks
Study NCT06033378 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood pressure elevation
Description: Increasing systemic blood pressure for measurement of cerebral blood flow changes
Study NCT05673122 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Implant(Flotecno)
Description: The implants It has a tapered body design and Sandblasting with Large grit that facilitates the osseointergration process.~made in Italy Flotecno srl via.Turati,38 20121 MILANO (Italia)
Study NCT04754295 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Goal-Directed Therapy
Description: Administration of fluids and vasoactive drugs guided by non-invasive haemodynamic monitoring
Study NCT04754295 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: STANDARD
Description: Administration of fluids and vasoactive drugs guided by standard vital signs monitoring
Study NCT06308783 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diaphragmatic Breathing
Description: 10 minutes each day during 6 weeks, before sleeping.
Study NCT06308783 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Global Postural Reeducation
Description: 10 minutes each day during 6 weeks, before sleeping.
Study NCT06277375 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Massage
Description: The application starts from the neck with small circular strokes with the thumbs. Surface strokes are performed with the palm of the hand from the base of the skull towards the sacral region. Then rhythmic strokes are repeated from the sacrum along the entire spine towards the skull.The application to the experimental group will be done 3 days a week for 10 minutes for a total of 30 minutes.
Study NCT05991817 — intervention group
Intervention type: PROCEDURE
Intervention: Surgery/general anesthesia
Description: Adult patients between the ages of 30 and 50 who are to undergo elective surgery under general anesthesia will have their spatial memory tested and interleukin 1beta and alpha tumor necrosis measured before and after surgery.
Study NCT05871476 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Hospital Cohort Care Intervention at the hospital
Description: There will be 3 different cohort groups for the patients: 1) Unknown CRE colonisation status with increased barrier precautions (all patients until screening results arrive will belong to this group unless there are available screening results from referral hospital), 2) CREpos, and 3) CREneg. CREpos patients (2) will be treated in one area of the ICUs by specially assigned nurses/personnel.
Study NCT05871476 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: , Household Education Communication Hygiene Intervention, Livestock Antibiotic Intervention
Description: The intervention will focus on two main measurable outcomes: 1) Decrease feco-oral-animal transmission route to prevent in-HH and community spread of CRE +/- CoRE. 2) Decrease unindicated community use of ABs for humans and animals. This WP focuses on a one health intervention in collaboration with local health authorities, developing and implementing an HH Education Communication Hygiene Intervention (HECHI) to improve HH hygiene and health management and reduce the risk of transmission between humans and animals, a Provider Engagement Intervention (PEI) to improve case management of common infection and decrease unindicated AB, and and a Livestock AB Intervention (LAI) to reduce the use of AB in livestock through improved biosecurity conditions and animal husbandry.
Study NCT05370118 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telerehabilitation physical activity behavioral (TPAB) intervention
Description: The intervention includes the behavior change techniques of self-monitoring of behavior, action planning, graded tasks, restructuring the physical and social environment, problem-solving, and prompts/cues.
Study NCT06514131 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pre-moistened wipes
Description: Patients receiving the experimental treatment will have perineal hygiene performed with the pre-moistened wipes without water
Study NCT04683575 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selenium Yeast
Description: oral medication
Study NCT04683575 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: oral medication
Study NCT06425640 — intervention group
Intervention type: BEHAVIORAL
Intervention: 24-hour movement behavior
Description: Cross-sectional observational study investigating the 24-hour movement behaviors and glucose control
Study NCT06055387 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Frailty intervention measures
Description: Providing specialized guidance:~* Physical Function and Fall History:~  * Prioritizing home safety for those with physical impairments.~ * Arranging rehab consultations when necessary.~* Nutrition:~  * Assessing diets and offering education.~ * Pre-treatment nutritionist assessments.~ * Monitoring weight, intervening if >5-10% loss, or >10% loss.~* Social Support:~  * Evaluating the needs of those without family support.~ * Referring to social services and introducing care resources.~* Cognition:~  * Detecting cognitive issues, addressing reversible causes.~ * Assessing decision-making and medication self-administration.~ * Refer to specialists when needed.~* Polypharmacy and Comorbidity:~  * Collecting medication data, ensuring adherence.~ * Noting chronic illnesses.~ * Collaborating with specialists or pharmacists for complex cases.~* Psychological:~  * Providing weekly support for psychological concerns.~ * Refer to specialists for assessments and treatment options.
Study NCT05391672 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Repair or Aumentation of partial ACL tear
Description: We will use repair technique in one grouo and Augmentation in the other group
Study NCT05096377 — intervention group
Intervention type: OTHER
Intervention: ESP block
Description: ESP block performed using ultrasound guidance. Diaphragmatic excursion was measured using M-mode ultrasound during normal breathing, deep breathing and with the sniff manoeuvre.
Study NCT06426745 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bowel preparation
Description: to compare bowel cleanliness, compliance, tolerability, and patient satisfaction of a single regimen versus a split regimen for colonoscopy.
Study NCT05759871 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: GnRH antagonist
Description: The GnRH antagonist in the control group (standard therapy) is administered from day 6 of FSH treatment at the dose of 0.25 mg per day until the triggering day and is injected each time immediately after the injection of FSH.
Study NCT05759871 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GnRH antagonist
Description: The GnRH antagonist in the control group (standard therapy) is administered from day 6 of FSH treatment at the dose of 0.25 mg per day until the triggering day and is injected each time immediately after the injection of FSH.
Study NCT04156659 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tisagenlecleucel
Description: A single intravenous (i.v.) infusion of CAR-positive viable T cells.
Study NCT05793658 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard capnography
Description: Patients undergoing colonoscopy under sedation were randomly assigned to receive standard capnography monitoring or modified capnography monitoring which can be achieved by tucking capnography probe under the face mask.74 patients were enrolled. Patient characteristics were well balanced between the two groups 37 patients in each group.
Study NCT05793658 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Modified capnography
Description: If Respiratory rate below 14 b/m: more sedation isn't not advised and the patient may develop airway obstruction and needs airway intervention ( like jaw thrust or oral airway) If respiratory rate more than 20 b/m it means this patient is prone to awake or to move and this patient in need for incremental dose of sedative drug ( e.g 20 to 30 mg propofol) Also roughly speaking respiratory rate from 16 to 18 b/m is the target
Study NCT03966989 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Performance Feedback
Description: Performance feedback offline that benchmarks providers' own performance to that of their peers
Study NCT05856968 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: continuous subcutaneous tissue closure
Description: The use of continuous subcutaneous tissue closure to determine which closure results in a lower rate of surgical site infection.
Study NCT05856968 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Interrupted subcutaneous tissue closure
Description: The use of interrupted subcutaneous tissue closure to determine which closure results in a lower rate of surgical site infection.
Study NCT04753801 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Thinking, writing and imagination
Description: All participants are asked to take some time to think and write about the respective intervention group's content. In some groups (after the writing exercise (approx. 15min)), participants are also asked to imagine that content or engage in a mindfulness activity or recall task for about 5 minutes.
Study NCT04753801 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Thinking, writing and imagination
Description: All participants are asked to take some time to think and write about the respective intervention group's content. In some groups (after the writing exercise (approx. 15min)), participants are also asked to imagine that content or engage in a mindfulness activity or recall task for about 5 minutes.
Study NCT05530005 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Manual Therapy
Description: Manual Therapy according to Kaltenborn Evjenth method. Exercises with PT resistance, massage.
Study NCT04780399 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Yangxue Qingnao pills
Description: 72 subjects in the Yangxue Qingnao pills group take 7.5g of Yangxue Qingnao pills each time, twice a day, 0.5 hours after breakfast and dinner, taking with warm water.
Study NCT04780399 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Yangxue Qingnao pills
Description: 72 subjects in the Yangxue Qingnao pills group take 5g of Yangxue Qingnao pills and 2.5g placebo identified to Yangxue Qingnao pills each time, twice a day, 0.5 hours after breakfast and dinner, taking with warm water.
Study NCT04780399 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 72 subjects in the placebo group take 7.5g placebo identified to Yangxue Qingnao pills each time, twice a day, 0.5 hours after breakfast and dinner, taking with warm water.
Study NCT05088356 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Purified regulatory T-cells (Treg) plus CD34+ HSPC
Description: Purified regulatory T-cells (Treg) plus CD34+ hematopoietic progenitor cells (CD34+ HSPC), followed by conventional T-cells (Tcon) Manufactured at SCTT Laboratory, dose 1x10\^6 cells/ kg to 3x10\^6 cells/kg
Study NCT05088356 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Fludarabine (160 mg/m2)